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The family Arenaviridae is divided into three genera: Mammarenavirus, Reptarenavirus,
and Hartmanivirus. The Mammarenaviruses contain viruses responsible for causing
human hemorrhagic fever diseases including New World viruses Junin, Machupo,
Guanarito, Sabia, and Chapare virus and Old World viruses Lassa, and Lujo virus.
These two groups of arenaviruses share the same genome organization composed
of two ambisense RNA segments. These segments contain four open reading frames
that encode for four proteins: the nucleoprotein, glycoprotein precursor, L protein,
and Z. Despite their genome similarities, these groups exhibit marked differences in
their replication life cycles. This includes differences in attachment, entry, and immune
evasion. By understanding the intricacy of replication in each of these viral species
we can work to develop counter measures against human diseases. This includes
the development of vaccines and antivirals for these emerging viral threats. Currently
only the vaccine against Junin virus, Candid#1, is in use as well as Ribavirin for
treatment of Lassa Fever. In addition, small molecule inhibitors can be developed to
target various aspects of the virus life cycle. In these ways an understanding of the
arenavirus replication cycle can be used to alleviate the mortality and morbidity of these
infections worldwide.
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FAMILY Arenaviridae
The family Arenaviridae is a viral family encompassing three newly separated genera:
Mammarenavirus, Reptarenavirus, and Hartmanivirus. As noted in the names, genus
Mammarenavirus encompasses those viruses that infect mammalian hosts whereas the
reptarenaviruses and hartmaniviruses infect reptilian hosts. The genus Mammarenavirus is further
sub-divided into the Old World and New World groups. Currently, the International Committee
for Taxonomy of Viruses (ICTV) recognizes 41 distinct viral species in the genus Mammarenavirus
(Maes et al., 2018). All members of the family have a negative sense, bi-segmented genome
consisting of a large (L) and small (S) segment. While varying between species on exact length,
on average the L segment of arenaviruses is 7.2 kb long whereas the S segment is 3.4 kb (Buchmeier
et al., 2007). Each segment contains two open reading frames (ORFs), utilizing an ambisense coding
strategy, separated by an intergenic region (IGR). This coding strategy allows for the expression of
early and late genes regulated by coding orientation. The L segment encodes the multi-functional
matrix protein (Z) and the large RNA-dependent RNA polymerase (RdRp) complex (LP). The S
segment encodes the viral nucleoprotein (NP) and glycoprotein precursor complex (GPC) that is
later cleaved into a stable signal peptide (SSP), GP1, and GP2. Utilizing only a limited number
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of proteins, arenaviruses are still able to infect, replicate, and
modulate host responses in complex and elegant fashions.
As stated previously, the genus Mammarenavirus is separated
into two main groups, Old World and New World, based on their
genetic, geographic, and epidemiological relationship (Wolff
et al., 1978; Charrel et al., 2008). The natural host for Old World
arenaviruses is the sub-family Murinae of the Muridae family of
mice. Old World arenavirus species include prototypic members
Lymphocytic choriomeningitis virus (LCMV) and Lassa virus
(LASV) as well as newly emerged Lujo virus. The Old World
viruses are generally geographically confined to the African
continent with the exception of LCMV that circulates globally in
the Mus musculus host. LASV strains were previously subdivided
into 4 distinct lineages based on genetic relationship (Bowen
et al., 2000; Manning et al., 2015). However, recent phylogenetic
evaluation postulates the emergence of a fifth and sixth lineage
(Manning et al., 2015; Whitmer et al., 2018). While the first
3 lineages cluster together geographically in Nigeria, lineage
4 LASV strains are found across several countries of West
Africa.
The New World arenaviruses are further divided into
four clades: A, B, C, and A/Rec (Clade D). The human
hemorrhagic pathogens Junin virus (JUNV), Machupo virus
(MACV), Guanarito virus (GTOV), Sabia virus (SABV), and
Chapare virus, cluster in clade B together with the prototypic
Tacaribe virus (TCRV). JUNV, MACV, GTOV, and SABV are
the causative agents of Argentine Hemorrhagic Fever (AHF),
Bolivian Hemorrhagic Fever (BHF), Venezuelan Hemorrhagic
Fever (VHF), and Brazilian Hemorrhagic Fever (BzHF),
respectively. Pichinde virus (PICV) is a prototypic clade A virus
that is not pathogenic to humans (Buchmeier et al., 1974).
To date, it has been widely utilized as a surrogate for LASV
pathogenesis, mimicking several disease manifestations in the
guinea pig model (Jahrling et al., 1981). Clade A/Rec (Clade
D) is hypothesized to be a recombination of clades A and
B (Charrel et al., 2001, 2002; Fulhorst et al., 2001; Archer
and Rico-Hesse, 2002). This clade includes North American
viruses Whitewater Arroyo virus (WWAV) and Bear Canyon
virus (BCNV). The New World arenaviruses are geographically
located on the South and North American continents. The
natural host for the New World viruses is the Sigmodontinae
sub-family of Muridae-family mice (Arenaviridae CDC, 2013),
with the exception of TCRV, which is found in Artibeus bats
(Salazar-Bravo et al., 2002). Recently, TCRV was isolated from
Amblyomma americanum ticks in Florida opening the possibility
of viral evolution aimed at adaptation to arthropod hosts
(Sayler et al., 2014). No further studies have been undertaken
to quantify the presence of other New World arenaviruses in
arthropods.
Recent surveillance has uncovered the circulation of novel
arenaviruses in Asia. Wenzhou Virus (WENV) was isolated in
China and is phylogenetically related to the Old World viruses
(Li et al., 2015). Further studies indicate that a Cambodian
strain of this virus can cause human infection (Blasdell, 2016).
These viruses have been found in several rodent vectors (Li
et al., 2015), leading to the possibility of a large natural host
range.
Both Old World and New World viruses cause significant
disease burden in their endemic areas of circulation. According
to the latest (Centers for Disease Control and Prevention [CDC],
2013, 2015) reports. LASV causes approximately 100,000–
300,000 clinical cases of Lassa fever (LF) a year and results in an
estimated 5,000 deaths (Lassa Fever CDC, 2015). These cases are
primarily localized in the Western African nations of Sierra Leon,
Liberia, Guinea, and Nigeria. In South America, JUNV, MACV,
GTOV, and Sabia cause fewer total numbers of disease cases but
human infections result in higher case fatality rates. According to
the most recent reports AHF, BHF, and VHF result in 15–20, 35,
and 33% case fatality rates, respectively (de Manzione et al., 1998;
Enria et al., 2004; Patterson et al., 2014).
Lassa virus and JUNV cause the prototypic human disease
manifestations for the Old World and New World viruses,
respectively. Lassa fever is a zoonotic disease usually resulting
from contact with infected murine feces or urine, however,
human-to-human transmission is possible. Lassa virus infections
have an average incubation time of 10 days and are usually
characterized by general flu-like symptoms: fever, malaise, and
headache. Patients that progress to severe cases of LF can then
develop hemorrhaging and/or neurologic involvement that may
be fatal (Frame et al., 1970; Monath et al., 1974; Monson et al.,
1984, 1987; McCormick et al., 1987; Hirabayashi et al., 1988;
Frame, 1989; Bausch et al., 2001; Enria et al., 2004). In LF
survivors, high rates of neurological sequelae have been observed,
with nearly 25% of survivors developing deafness (Liao et al.,
1992; WHO, 2005; Okokhere et al., 2009). JUNV infection
also occurs from exposure to infected murine feces and urine,
mostly associated with agricultural activities, and may develop
into AHF with an incubation time of 6–14 days. Like LF,
AHF initially presents with flu-like symptoms including fever,
malaise, anorexia, and headache. Disease progression can result
in neurologic symptoms, leukopenia, and thrombocytopenia.
One hallmark of AHF as well as other New World virus infections
is the large spike of interferon production during infection that is
not seen in Old World virus infections (Enria et al., 2004).
VIRAL LIFE CYCLE
Virus Entry
Virus particles initially enter the host through inhalation of
aerosolized particles. It is hypothesized that alveolar macrophages
are the first cell types infected due to the route of infection and
virus present in macrophages early in infection (Gonzalez et al.,
1980). While arenaviruses and antigen have been detected in
the pulmonary epithelium of infected humans and animals, it is
unclear whether these cells are the initial targets (Walker et al.,
1982; Hall et al., 1996). These initial infected macrophages can
then move to the draining lymph node, resulting in migration
and spread of the virus to various tissues (Gonzalez et al.,
1980; Buchmeier et al., 2013). Aside from the different cellular
receptors, Old World and New World viruses also utilize different
entry pathways into the cell. The process of entry is initiated
when the GP1 attaches to the corresponding cellular receptor
Old World viruses, such as LASV and LCMV as well as Clade
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C New World viruses utilize α-dystroglycan, an extracellular
matrix protein commonly found in the basement membrane
(Cao et al., 1998; Spiropoulou et al., 2002), for entry. LUJV was
recently discovered to utilize the neurophin (NRP)-2 receptor
to mediate entry (Raaben et al., 2017). Recently, TAM family,
C-type lectins, and AxI have also been implicated as candidate
receptors for LASV and LCMV (Shimojima and Kawaoka, 2012;
Shimojima et al., 2012; Fedeli et al., 2017). This raises the
possibility of multiple receptors and entry methods for Old
World arenaviruses. For Clade B New World arenaviruses,
GP1 attaches to transferrin receptor-1 (Radoshitzky et al., 2007;
Helguera et al., 2012). TIM family proteins have also been
shown to enhance New World arenavirus infectivity (Jemielity
et al., 2013). Additionally, siRNA screens indicate that voltage-
gated calcium channel (VGCC) subunits play a role in JUNV
cell fusion and cellular entry (Lavanya et al., 2013), indicating
possible co-receptors used in New World arenavirus entry. To
date, the cellular receptor utilized by Clade A New World
arenaviruses has yet to be established. After GP1 attaches to
the cellular receptor, the virion is endocytosed. New World
viruses, such as JUNV, are endocytosed through a clatherin-
dependent pathway, whereas the Old World viruses proceed
through an unknown clatherin-independent pathway (Rojek
et al., 2008b; Pasqual et al., 2011). This entry indicates the
role of Endosomal Sorting Complex Required for Transport
(ESCRT) proteins for successful cellular entry (Pasqual et al.,
2011). Recent studies additionally indicate a possible role of
macropinocytosis pathways in Old World viral entry (Oppliger
et al., 2016) (see Table 1 for summary of arenavirus entry).
Following endocytosis and acidification of the endosome, GP2,
a class I fusion protein, facilitates membrane fusion and the
release of the viral genome and replication complexes into the
cell (Eschli et al., 2006). Additional evidence has shown that
in the process of LASV entry into the cell acidification of the
endosome results in an altered G1 receptor binding domain. This
results in GP1 binding Lysosomal-associated membrane protein
1 (LAMP1) and potentially assisting in the fusion activity of GP2
(Cohen-Dvashi et al., 2016). LUJV has been shown to utilize
the same strategy but binding to CD63 instead of LAMP1 to
TABLE 1 | Arenavirus receptor usage and cellular entry.
Virus/group Major cellular receptor Entry pathway
Old world
LASV, LCMV α-dystroglycan (Cao et al.,
1998)
Clatherin-independent
(Rojek et al., 2008b; Pasqual
et al., 2011)
LUJV NRP-2 (Raaben et al., 2017) Unknown
New world
Clade A viruses Unknown Unknown
Clade B viruses Transferrin receptor-1
(Radoshitzky et al., 2007;
Helguera et al., 2012)
Clatherin-dependent (Rojek
et al., 2008b)
Clade C viruses α-Dystroglycan (Spiropoulou
et al., 2002)
Unknown
LASV, Lassa virus; LCMV, Lymphocytic choriomeningitis virus; LUJV, Lujo virus.
mediate fusion and escape from the endosome (Raaben et al.,
2017).
Replication
See Figure 1 for an outline of arenavirus replication.
Once the replication complex has been released into the
cytoplasm, the viral LP, in conjunction with NP, begins replication
of the viral genome. The association of LP, NP, and the viral
genome in the cell is considered to be the minimum requirement
for initiation of replication (Lee et al., 2000; López et al.,
2001; Hass et al., 2004). The LP contains 4 proposed domains
(Brunotte et al., 2011). Domain 1 contains the endonuclease
domain hypothesized to facilitate acquisition of 5′ mRNA caps
critical to transcription during the replication cycle. The 5′
mRNA cap is an m7G structure that is found on the 5′ end
of eukaryotic mRNA. This cap serves the purposes enhancing
mRNA translation and stability (Both et al., 1975; Furuichi
et al., 1977). This LP function is due to the domain’s sequence
and structure homology with influenza cap-acquisition protein
PA as well as enzymatic studies utilizing LCMV Domain 1
expression (Morin et al., 2010). Domain 3 of the LP contains
conserved sequences identified as elements of an RdRp (Vieth
et al., 2004). Domains 2 and 4 have as yet unknown functions
that may relate to stability, regulation, or other protein-protein
interactions (Brunotte et al., 2011). Replication is initiated by LP
and NP acquiring 5′ caps from host mRNA. These caps prime
the initiation of early gene transcription: NP and LP ORFs on
the S and L segments, respectively. Since the arenavirus RNA
is negative sense, it is unable to be directly translated in its
genomic form. This necessitates nascent RNA-dependent RNA
transcription that is produced 5′–3′. The NP and LP ORFs are
found in this first transcribed region leading to their initial
production as early products (Meyer et al., 2002). Transcription
is terminated through the utilization of intergenic hairpin
structures found in both the L and S segment IGR (Pinschewer
et al., 2005). Translated NP binds to viral RNA to facilitate further
transcription, replication, and eventually assembly of progeny
virus. Crystal structure analysis of NP has shown that the N
terminal domain may accommodate the “stolen” host mRNA cap
facilitating further transcription (Qi et al., 2010).
The transition from early gene products to late gene products
is facilitated through the production of anti-genomic RNA
(Meyer et al., 2002). This is produced when the polymerase
reads through the IGR hairpins and makes a complimentary
RNA genome. These anti-genomic RNAs are then utilized as the
template for transcribing mRNAs from the Z and GPC ORFs.
Since they require the production of antigenomic RNA and later
genomic mRNA (Meyer et al., 2002), Z and GPC constitute
the late gene products in the viral replication cycle. GPC is
translated in the endoplasmic reticulum where it undergoes
N-linked glycosylation and cleavage of the SSP from GP1/GP2 by
SPase (Eichler et al., 2003). The majority of type 1 fusion proteins
are cleaved by the host furin like proteases, but arenavirus
GPC utilizes a divergent pathway (Harrison, 2015). Precleaved
GPC is additionally cleaved between GP1 and GP2 by Subtilisin
Kexin Isozyme 1/Site 1 Protease (SKI-1/S1P) into the final SSP,
GP1, and GP2 in the trans-Golgi network (Lenz et al., 2001;
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FIGURE 1 | Arenavirus life cycle.
Rojek et al., 2008a). These three cleaved products stay associated
and form a tripartite glycoprotein spike in the cellular plasma
membrane. This again is unique in the fact that the signal peptide
is incorporated into the final virion instead of being degraded
following final protein localization. The Z protein is a short
peptide from 90 to 99 aa in length depending on viral species
(Capul et al., 2011). This protein contains three domains that
contribute to its multifunctional nature. The N-terminal domain
contains a myristylation site that allows the protein to localize and
anchor itself to the plasma membrane (Perez et al., 2004). The
central domain contains a Really Interesting New Gene (RING)
domain that chelates Zinc ions. This domain has been shown
to be critical for Z-NP and Z-LP interaction but not for Z-GPC
interaction (Wilda et al., 2008; Capul et al., 2011; Loureiro et al.,
2011). Finally, the C-terminal domain of Z contains proline-
rich motifs known to interact with the ESCRT machinery. This
interaction is due to interactions of the late-domain of Z with the
ESCRT proteins (Perez et al., 2003). Within arenaviruses, there
are many different late domains that fall into several large groups.
In general, Old World viruses contain the PTAP and PPPY
amino acid domains whereas the New World viruses generally
contain the PT/SAP amino acid domain (Urata and de la Torre,
2011).
Assembly and Budding
Interaction with the ESCRT machinery allows for transport of Z
to the membrane to support virion budding. Specifically, the late
domain of Z has been show to interact with Tumor susceptibility
gene 101 (Tsg-101) of the ESCRT pathway (Wilda et al., 2008).
Recently, it has been suggested that the late domain motif of
LCMV drives the production of defective interfering particles
(Ziegler et al., 2016). This is thought to be mediated by the
PPPY late domain found in some Old World viruses but not
in New World (Ziegler et al., 2016). Accumulation of Z protein
performs many late-replication functions in the cell. First, the
Z protein interacts with LP and inhibits polymerase function
(Kranzusch and Whelan, 2011). In TACV, the LP-Z interaction
has been mapped to residues in Domain 1 and Domain 3 of the L
polymerase (Perez et al., 2003). This interaction, along with NP-Z
interactions, facilitates translocation of the replication complex
to the cell membrane in preparation for virion budding that
occurs through the interaction of the Z late domain with Tsg-101.
Finally, accumulation of the Z protein at the membrane results
in viral budding and the production of new, infectious virions. In
the absence of other viral proteins and genomic RNA, Z has been
shown to initiate self-budding resulting in production of virus-
like particles which is why it is considered to be the minimal
budding factor for the virus (Hoenen et al., 2007; Ziegler et al.,
2016).
TABLE 2 | Arenavirus immune evasion.
Viral protein Mechanism of immune evasion
NP Decreased Type I IFN through inhibition of IRF-3 activation
(except TACV) (Martínez-Sobrido et al., 2007, 2008)
Decreased IFN-β production through inhibition or avoidance
of PKR signal cascade (Huang et al., 2017; King et al.,
2017)
New world Z Decreased IFN-β production through inhibition of RIG-I
signal cascade (Fan et al., 2010)
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IMMUNE EVASION
During replication, viral evasion from the immune system is
critical for productive replication and dissemination in the host.
Arenaviruses have been shown to accomplish this in many ways.
First, the NP protein has been shown to have strong anti-
immune functions in the cell. Interferon regulatory factor 3
(IRF-3) is an important component of the type 1 interferon
response. Studies have shown that NP inhibits IRF-3 activation
of downstream genes resulting in a limited interferon response
(Martínez-Sobrido et al., 2007, 2008). Interestingly, TCRV does
not exhibit this same function in the NP perhaps suggesting
differential adaptation to an alternative host. The downregulation
of interferon-beta in infected cells has been linked to the
exonuclease function of the C terminal domain of NP (Qi et al.,
2010). This results in the degradation of small dsRNAs that
may trigger host signal peptides. One of these potent cellular
defenses against viral infection is the dsRNA activated protein
kinase (PKR). PKR is able to recognize dsRNA in the cell and
become phosphorylated (García et al., 2006). Phosphorylated
PKR triggers phosphorylation of other signal proteins as well as
the phosphorylation of transcription factors needed to halt viral
replication. While some studies have shown that the NP of JUNV
is able to stop phosphorylated PKR from resulting in downstream
signally and phosphorylation of translation factor eIF2α (King
et al., 2017) others indicate that JUNV and MACV infections
still produce phosphorylated eIF2α (Huang et al., 2017). Recent
studies have demonstrated that while JUNV and MACV activate
PKR, LASV infection does not (Huang et al., 2017). It was also
shown that this was not due to a prevention of PKR activation,
but likely an avoidance of detection. In this way LASV may avoid
activation of immune responses in infected cells.
In New World viruses, the Z protein has been shown to
also play a role in immune evasion. The Z protein binds to the
retinoic acid-inducible gene I (RIG-I) and inhibits interferon-
beta production (Fan et al., 2010). RIG-I normally acts as a
cellular sensor for double stranded RNA and activates interferon
production through a signal cascade (Loo and Gale, 2011).
The binding with New World viral Z prevents RIG-I from
binding mitochondrial antiviral signaling protein (MAVS), the
next protein in the signaling cascade. This halts interferon-beta
production and allows the virus to replicate without the presence
of a robust immune response (see Table 2 for a summary of
arenavirus immune evasion).
Another way in which arenaviruses may activate the innate
immune system and promote a Type I interferon response is
through the activation of various Toll-like receptors (TLRs)
(Vidya et al., 2018). JUNV infection has been shown to induce
a Type I response mediated through activation of TLR 2 (Cuevas
et al., 2011; Cuevas and Ross, 2014). However, induction of this
response did not result in decreased viral replication in brain
cells. Old World LCMV has been shown to produce a TLR 7 and
TLR 9 mediated Type I response (Lee et al., 2009; Macal et al.,
2012; Walsh et al., 2012; Buechler et al., 2015). A productive TLR
7 mediated response was also shown to be necessary for robust
adaptive immune responses as well as monocyte recruitment
(Macal et al., 2012; Walsh et al., 2012). Interesting, chronic LCMV
infection of dendritic cells inhibited the TLR 7 and 9 responses
of cells treated with each respective agonist (Cuevas and Ross,
2014) in an ex vivo model. When these agonist were used to
treat in vitro cells chronically infected with LCMV, there was no
significant difference in the TLR 7 and 9 response. Further studies
are necessary to determine the exact contributions of each of
these signaling pathways and the viral impact on their activation.
Finally, Old World and New World viruses appear to exhibit
differences in terms of immune protection against fatal infection.
In New World JUNV, passive antibody transfer from immune
sera has been shown to dramatically improve survival of infection
in humans (Maiztegui et al., 1979; Ruggiero et al., 1986). Old
World LASV, however, does not show any improved survival
upon treatment with immune sera (McCormick et al., 1986). It
is important to note that some patients treated with the JUNV
immune plasma did develop late neurological complications.
These results indicate an importance of a B cell mediated
response in JUNV infection and a likely T cell mediated response
in LASV infection.
CONCLUSION
The family Arenaviridae encompasses a large variety of viral
species found in a variety of animal hosts. Within the genus
Mammarenavirus, great diversity is still seen in terms of cellular
entry strategies, and host immune evasion. Old World and
New World viruses demonstrate a marked divergence in these
pathways that makes an understanding of the varied mechanisms
crucial to the study of their replication and pathogenesis. Within
these broader groups there is still an observed divergence in
cellular receptor usage and natural host range adding additional
complexity to their life cycles. As arenavirus research continues,
similarities and differences between the varied species will further
allow for the development of pathogenesis models and treatments
that are encompassing for species that share those similarities,
but not be mistakenly utilized on divergent members. This
refinement of arenavirus biology is crucial for all future research
and development utilizing these agents.
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